Viking Therapeutics, Inc. Gains 69.3%
Tue, Mar 28, 2023 at 07:10 PM
Viking Therapeutics, Inc. (VKTX:NASDAQ) soared at $15.44, a gain of 69.3%. On Tue, Mar 28, 2023, VKTX:NASDAQ hit a New 2-Week High of $15.44. The stock got featured on our News Catalysts scanner on Tue, Mar 28, 2023 at 09:04 AM in the 'MISCELLANEOUS' category. From Tue, Mar 14, 2023, the stock recorded 50.00% Up Days and 54.55% Green Days
About Viking Therapeutics, Inc. (VKTX:NASDAQ)
Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.
Top 10 Gainers:
- Biomea Fusion Inc. (BMEA:NASDAQ), 99.03%
- Viking Therapeutics, Inc. (VKTX:NASDAQ), 69.3%
- Oscar Health Inc. Class A (OSCR:NYSE), 56.27%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 50.17%
- Pyxis Oncology Inc. (PYXS:NASDAQ), 42.59%
- Bird Global Inc. Class A (BRDS:NYSE), 42.19%
- MGO Global Inc. (MGOL:NASDAQ), 33.33%
- Knightscope Inc. (KSCP:NASDAQ), 31.19%
- Loop Industries, Inc. (LOOP:NASDAQ), 23.41%
- Tiziana Life Sciences PLC (TLSA:NASDAQ), 22.4%